Nu Skin Celebrates Record-Breaking Global Convention

Global Launch of Anti-aging Science and Products Represents 'Sweet Spot' for
Distributor Business Opportunity

PROVO, Utah, Oct. 29 /PRNewswire-FirstCall/ -- Nu Skin Enterprises, Inc.
(NYSE: NUS) concluded its 25th Anniversary Convention in Los Angeles with
record attendance, record product sales and record contributions to its
nonprofit foundation. The biannual global distributor convention attracted
more than 12,000 distributors from the company's 48 international markets. The
largest delegations of sales representatives came from the United States,
Japan and Korea.

"ageLOC represents the biggest global product launch in Nu Skin history," said
Truman Hunt, Nu Skin president and chief executive officer. "Sales force
enthusiasm for our new ageLOC daily skin care system produced unprecedented
demand with sales exceeding our most liberal revenue projections. By
developing products with an understanding of the genetic basis of aging
through our proprietary ageLOC science, we believe we are continuing to
provide the premier anti-aging business opportunity for our sales
representatives -- one that represents a 'sweet spot' by leveraging a growing
global megatrend with exclusive and scientifically validated products that
help people look and feel young."

In addition to the new ageLOC product lineup, the company also launched
several business marketing tools including an online opportunity video
focusing on planning for the future
(http://www.youtube.com/nuskincorporate#p/u), new smart phone applications and
an aging simulator tool to help start conversations on anti-aging products.
The company's web site also received a facelift and is available at
http://www.nuskin.com.

ageLOC Product Introductions
The company unveiled a lineup of revolutionary anti-aging products -- a
comprehensive daily skin care system that is clinically tested to transform
skin to reveal a more youthful appearance beginning after just seven days of
use. The ageLOC Transformation set is infused with ingredients that represent
next generation anti-aging skin care science to target the sources, as well as
the signs, of aging.

The set is comprised of four products designed to reduce the appearance of
aging in the skin. The star product, ageLOC Future Serum, combines the
benefits of many different anti-aging products to reveal younger looking skin
in eight key ways beginning in just seven days. Other products in the set
include ageLOC Gentle Cleanse & Tone, ageLOC Radiant Day SPF 22 and ageLOC
Transforming Night.

ageLOC daily skin care products will be available globally in the first half
of 2010, led by launches in Japan, North America and Europe in January and
followed soon thereafter in South Korea, Greater China and Southeast Asia.

New Research Partnerships
Nu Skin also announced two key research partnerships with Stanford University
and LifeGen Technologies. Researchers at Stanford have focused on profiling
gene expression during human development and aging, and have also explored
novel modes of gene control in aging skin. Nu Skin's agreement with Stanford
aims to increase the understanding of fundamental aging mechanisms in humans
by translating insights from basic science into human application. The
agreement also includes access to Stanford's expertise in dermatological
clinical trials.

Nu Skin will also collaborate with LifeGen in an exclusive agreement by
leveraging LifeGen's proprietary methods regarding gene expression profiling
and pathways affected by aging. LifeGen was co-founded in November 2000 by
Richard Weindruch, Ph.D., and Tomas Prolla, Ph.D., professors at the
University of Wisconsin-Madison and leaders in the fields of gerontology and
genetics. The mission of LifeGen Technologies is to discover the genetic basis
of the aging process with the ultimate goal of increasing a healthy life span.
LifeGen's pioneering research has resulted in several pending patents, and
ongoing research undertaken in collaboration with Nu Skin is expected to yield
further important intellectual property. LifeGen's patent for the use of "gene
expression profiling" as a method to measure the progression of the aging
process at the molecular level in individual organs is expected to be a key
component of the partnership.

The Nu Skin and Pharmanex labs in Provo, Utah, have been renamed to "Nu Skin
Enterprises Center for Anti-aging Research" to focus on the company's premier
anti-aging science for development of both personal care and nutritional
products. Similarly, the company's scientific advisory boards have been
combined to create the Nu Skin Anti-aging Scientific Advisory Board, with the
addition of two key scientists, Drs. Weindruch and Prolla from LifeGen
Technologies.

Nu Skin Corporate Social Responsibility
As part of its mission to be a force for good in the world by improving lives,
Nu Skin's "force for good" culture is a key component of the company's brand
and includes a nonprofit foundation, a social business initiative and outreach
efforts in local markets around the world.

On the eve of the convention, the Nu Skin Force for Good Foundation hosted a
fundraising gala in the historic Millennium Biltmore hotel in downtown Los
Angeles. With approximately 500 guests in attendance, the Foundation raised
more than US$750,000. One hundred percent of donations are used for projects
around the world that offer hope for children to have a life free from
disease, illiteracy and poverty (http://www.forceforgood.org). California
Governor Arnold Schwarzenegger made a surprise appearance at the closing
session of the convention and accepted a US$100,000 grant from the Nu Skin
Force for Good Foundation to help fund after-school programs in California.

The Company
For 25 years, Nu Skin Enterprises, Inc. has been demonstrating its tradition
of innovation through its comprehensive anti-aging product portfolio,
independent business opportunity and corporate social responsibility
initiatives. Nu Skin's scientific leadership in both skin care and nutrition
has established Nu Skin as a premier anti-aging company, evidenced in its
unique ageLOC(TM) science that addresses aging at its source. The company's
anti-aging product portfolio features the new ageLOC daily skin care system
and Future Serum, as well as the Galvanic Spa® System II, Tru Face® Essence
Ultra, LifePak® nano and the g3 nutrition beverage. A global direct selling
company, Nu Skin operates in 48 markets worldwide and has more than 750,000
independent sales representatives. Nu Skin Enterprises is traded on the New
York Stock Exchange under the symbol "NUS." More information is available at
http://www.nuskin.com.

Please note:This press release contains forward-looking statements within the
meaning of Section 21E of the Securities Exchange Act of 1934 that represent
the company's current expectations and beliefs, including, among other things:
(i) expectations regarding the company's development and launch of new
products, and other innovation efforts; and (ii) expectations and beliefs
regarding the company's research collaboration with Stanford University and
LifeGen Technologies. The forward-looking statements and related assumptions
involve risks and uncertainties that could cause actual results and outcomes
to differ materially from any forward-looking statements or views expressed
herein. These risks and uncertainties include, but are not limited to: (a) any
risks that the company's development and launch of new products may differ
from expectations; (b) regulatory risks associated with the company's
products, which could inhibit the company's ability to market such products in
a market if such products are classified as a drug, or if the company is
unable to obtain necessary product registrations in a timely manner; (c) any
risks that Stanford University's or LifeGen Technologies' intellectual
property, ongoing research or collaboration with the company may differ from
expectations or fail to provide anticipated results. The forward-looking
statements contained herein are further qualified by a detailed discussion of
associated risks set forth in the documents filed by the company with the
Securities and Exchange Commission, including the company's Annual Report on
Form 10-K filed on February 27, 2009 and Quarterly Reports on Form 10-Q filed
on May 8, 2009 and August 7, 2009. The forward-looking statements set forth
the company's beliefs as of the date of this release, and the company assumes
no duty to update the forward-looking statements contained in this release to
reflect any change except as required by law.

SOURCE Nu Skin Enterprises, Inc.

Kara Schneck, +1-801-345-2116, kschneck@nuskin.com, or Jordan Karpowitz,
+1-801-345-2187, jkarpowitz@nuskin.com, both of Nu Skin Enterprises, Inc.